PRIMARY STUDY
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain
Key Findings: The authors report that in the treatment context of chronic neuropathic pain several studies come to divergent conclusions regarding the efficacy of cannabis-based therapeutics.
Type of Study: Meta-analysis
Study Result: Inconclusive
Research Location(s): Canada, Germany
Year of Pub: 2022
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Citation: Petzke F, et al. Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain. CNS Drugs. 2022; 36:31-44. doi: 10.1007/s40263-021-00879-w
Authors: Petzke F, Tölle T, Fitzcharles MA, Häuser W
